pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,692 catalysts · 5,347 phase readout · 2,315 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 20 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: pdufa×type: approval×type: phase readout×clear all
type
  • phase readout5,347
  • 8k filing2,315
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT06800898: Orexin Gene in Anorexia Nervosa

Sponsor: Istituto Auxologico Italiano. Phase: . Conditions: Anorexia Nervosa

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07634263: Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods Study

Sponsor: Odense University Hospital. Phase: . Conditions: Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Multiple Myeloma Progression, Multiple Myeloma Refractory

full page →ctgov ↗
›RECRUITINGphase readoutNCT06700187: Frequency of Interrupting Sitting and Cognitive Function

Sponsor: Maastricht University Medical Center. Phase: NA. Conditions: Sedentary Behaviors, Breaking Prolonged Sitting With Physical Activity

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07386587: Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis

Sponsor: University of Child Health Sciences and Children's Hospital, Lahore. Phase: PHASE3. Conditions: Juvenile Idiopathic Arthritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07315087: CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases

Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE1. Conditions: SLE - Systemic Lupus Erythematosus, SSc-Systemic Sclerosis, IIM- Idiopathic Inflammatory Myopathies, ANCA Associated Vasculitis (AAV), Connective Tissue Disease-Associated Thrombocytopenia, SLE-ITP

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07600463: UVC in Prevention of Surgical Wound Infection

Sponsor: Ville Leinonen. Phase: NA. Conditions: Hydrocephalus

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02777593: Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2

Sponsor: W.L.Gore & Associates. Phase: NA. Conditions: Aortic Aneurysm, Thoracic, Aorta; Lesion

full page →ctgov ↗
›RECRUITINGphase readoutNCT05583721: Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET

Sponsor: St. Jude Children's Research Hospital. Phase: PHASE2. Conditions: Sickle Cell Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07646314: Comparative Effects of Post-Isometric Relaxation and Reciprocal Inhibition Techniques inPiriformis Syndrome

Sponsor: Riphah International University. Phase: NA. Conditions: Piriformis Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT06308614: Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

Sponsor: Estetra. Phase: PHASE2. Conditions: Sexual Dysfunction, Physiological

full page →ctgov ↗
›RECRUITINGphase readoutNCT05145816: Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

Sponsor: University of Texas Southwestern Medical Center. Phase: PHASE1. Conditions: AL Amyloidosis, Amyloidosis

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT04996316: MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

Sponsor: OHSU Knight Cancer Institute. Phase: . Conditions: Breast Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT05709106: A Prospective Real World Study of Rimegepant in the Treatment of Migraine

Sponsor: Ruijin-Hainan Hospital Shanghai Jiao Tong University School Of Medicine. Phase: . Conditions: Migraine

full page →ctgov ↗
›RECRUITINGphase readoutNCT05085704: Brain Metabolism Observed at 3 Tesla or 7 Tesla in Health and Metabolic Disease

Sponsor: Weill Medical College of Cornell University. Phase: . Conditions: Glut1 Deficiency Syndrome 1, Glucose Metabolism Disorders, Epilepsy, Glut1 Deficiency Syndrome 1, Autosomal Recessive, Glucose Transporter Type 1 Deficiency Syndrome, Glucose Transporter Protein Type 1 Deficiency Syndrome, Glucose Transport Defect

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07492433: Risk Factors, Incidence, and Clinical Impact of Intraluminal Thrombosis Following FET and TEVAR

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. Phase: . Conditions: Intraluminal Thrombosis, Tevar, FET

full page →ctgov ↗
›COMPLETEDphase readoutNCT01417533: A Natural History Study of Patients With GNE Myopathy and GNE-Related Diseases

Sponsor: National Human Genome Research Institute (NHGRI). Phase: . Conditions: GNE Myopathy, GNE Related Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT07401147: Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management During Labor.

Sponsor: Ricardo A Gutierrez Ramirez, MD, MSc, FACOG. Phase: NA. Conditions: Labor Pain

full page →ctgov ↗
›TERMINATEDphase readoutNCT03373084: Imaging Location of Hamstring Muscle Lesions in Sport and Relationships With Injury Mechanism.

Sponsor: Centre Hospitalier Universitaire de Saint Etienne. Phase: . Conditions: Sport Injury, Hamstring Muscle Lesions

full page →ctgov ↗
›RECRUITINGphase readoutNCT06776952: A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Sponsor: Evopoint Biosciences Inc.. Phase: PHASE3. Conditions: Relapsed/Refractory Peripheral T Cell Lymphoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT05085249: Improving Goal Directed Medical Therapy for Device Clinic Patients With Reduced EF at UOHI: a QI Initiative (VIGILANT)

Sponsor: Ottawa Heart Institute Research Corporation. Phase: . Conditions: Heart Failure

full page →ctgov ↗
›RECRUITINGphase readoutNCT06019949: Spinal Cord Stimulation for Respiratory Rehabilitation in Patients With Chronic Spinal Cord Injury

Sponsor: University of Louisville. Phase: NA. Conditions: Spinal Cord Injuries, Respiration Disorders

full page →ctgov ↗
›COMPLETEDphase readoutNCT05602038: Comparative Study on the Effect of Quadratus Lumborum Block Versus Intrathecal Morphine on the Incidence of Chronic Pain Post Caesarean Section

Sponsor: Menoufia University. Phase: NA. Conditions: Chronic Post Cesarean Pain

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07545538: Carbohydrate Loading in Lowering Perioperative Insulin Resistance in Pediatric Surgery

Sponsor: Gadjah Mada University. Phase: NA. Conditions: Insulin Resistance

full page →ctgov ↗
›RECRUITINGphase readoutNCT06299748: A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.

Sponsor: argenx. Phase: . Conditions: Myasthenia Gravis, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03625648: Pentoxifylline in Diabetic Kidney Disease

Sponsor: VA Office of Research and Development. Phase: PHASE4. Conditions: Diabetic Kidney Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07495748: Comparative Evaluation of Topical Metformin and Topical Tranexamic Acid in Melasma

Sponsor: Foundation University Islamabad. Phase: NA. Conditions: Melasma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07179848: Safety and Feasibility of Temporal Interference Brain Stimulation for Treatment in Psychiatric Disorders

Sponsor: Taipei Veterans General Hospital, Taiwan. Phase: PHASE1. Conditions: Health Adults, Temporal Interference Stimulation, Safety and Effectiveness, Crossover Study

full page →ctgov ↗
›RECRUITINGphase readoutNCT07560878: Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression

Sponsor: Mclean Hospital. Phase: EARLY_PHASE1. Conditions: Major Depression

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07397078: Clinical Accuracy Validation of the Moni-Patch Temperature Monitoring Patch System

Sponsor: Murata Vios, Inc.. Phase: NA. Conditions: Body Temperature, Febrile

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04617678: A Comprehensive Approach to Head and Neck Cancer Prehabilitation

Sponsor: Sanford Health. Phase: NA. Conditions: Cancer of Head and Neck

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07525778: Evaluating WhatsOK Helpline for Youth With Concerns About Sexual Thoughts and Behaviors

Sponsor: Center for Violence Prevention Research Inc. Phase: NA. Conditions: Mental Health, Social Support, Perceived Self-efficacy, Sexual Behavior

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07575178: Obstacle Course Versus Neuromotor Task Training in Children With DCD

Sponsor: Riphah International University. Phase: NA. Conditions: Developmental Coordination Disorder (DCD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT03910478: Dried Blood Spot Testing of CMV Detection in HCT Recipients

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: NA. Conditions: Cytomegalovirus Infection

full page →ctgov ↗
›RECRUITINGphase readoutNCT06892743: Analgesic Efficacy of Ultrasound-guided External Oblique Intercostal Plane Block Versus Posterior Transversus Abdominis Plane Block in Patients Undergoing Open Nephrectomy

Sponsor: Cairo University. Phase: NA. Conditions: Postoperative Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07224243: Impact of Intraoperative Oxygenation Practices on Patient Outcomes

Sponsor: Frederic T Billings IV. Phase: NA. Conditions: Surgeries Undergoing General Anesthesia

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT03295279: WTC Chest CT Imaging Archive

Sponsor: Icahn School of Medicine at Mount Sinai. Phase: . Conditions: Chronic Airway Disease, Interstitial Lung Disease, Lung Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06631079: Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1/PD-L1 Therapy in Patients With Solid Tumors

Sponsor: NEC Bio B.V. Phase: PHASE1. Conditions: Solid Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT07483879: Biomarkers of Acute Organ Injury in Pediatric Newly Diagnosed Type 1 Diabetes

Sponsor: Aristotle University Of Thessaloniki. Phase: . Conditions: Type 1 Diabetes Mellitus, Diabetic Ketoacidosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06692179: An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of A Suspension of Freeze-dried Microbiota In Patients Undergoing Colon Resection

Sponsor: University of Minnesota. Phase: PHASE1. Conditions: Recurrent Clostridioides Difficile Infection, Colonic Surgery

full page →ctgov ↗
›TERMINATEDphase readoutNCT05576896: Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory

Sponsor: Northwestern University. Phase: PHASE2. Conditions: Stage IV Colorectal Cancer Positive for BRAF V600E Mutation, Colorectal Cancer, Colorectal Cancer Stage IV

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07334496: A Study to Evaluate the Biosimilarity of GLR1044 Injection and Dupilumab Injection (Dupixent®) in Healthy Adult Male Subjects

Sponsor: Gan & Lee Pharmaceuticals.. Phase: PHASE1. Conditions: Biosimilarity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07520162: A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab

Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Chronic Rhinosinusitis With Nasal Polyps

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06743646: Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy

Sponsor: Chigenovo Co., Ltd. Phase: PHASE3. Conditions: Bietti Crystalline Corneoretinal Dystrophy, Bietti Crystalline Dystrophy

full page →ctgov ↗
›RECRUITINGphase readoutNCT05464888: Animal Assisted Therapy in Pediatric Dentistry

Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Anxiety

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07621861: Holy Qur'an Versus Music Sound on Sleep Quality in Children Undergoing Chemotherapy

Sponsor: Rawand Shafeeq Ali. Phase: NA. Conditions: Sleep Wake Disorders

full page →ctgov ↗
›RECRUITINGphase readoutNCT05216042: GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Cardiovascular Diseases, Natriuretic Peptides, Cardiometabolic Diseases, Energy Expenditure, Glucose Metabolism, Exercise, Obesity

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04993742: Effects of Pregnancy-Specific Anxiety on Placental Inflammatory and Oxidative Stress Response and Birth Outcomes

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine. Phase: NA. Conditions: Placental Dysfunction, Prenatal Stress

full page →ctgov ↗
›COMPLETEDphase readoutNCT06054386: Attention Bias Modification Training for Social Phobia (ABMSP)

Sponsor: University of Wisconsin, Milwaukee. Phase: NA. Conditions: Social Anxiety Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04459273: Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

Sponsor: Jonsson Comprehensive Cancer Center. Phase: PHASE1. Conditions: Bladder Carcinoma, Cervical Carcinoma, Cholangiocarcinoma, Hematopoietic and Lymphoid Cell Neoplasm, Hepatocellular Carcinoma, Malignant Adrenal Gland Neoplasm, Malignant Brain Neoplasm, Malignant Pleural Neoplasm, Malignant Skin Neoplasm, Malignant Solid Neoplasm, Malignant Testicular Neoplasm, Malignant Thymus Neoplasm, Neuroendocrine Neoplasm, Thyroid Gland Carcinoma, Urothelial Carcinoma, Cancer of Unknown Primary Site

full page →ctgov ↗
›AVAILABLEphase readoutNCT05982873: Expanded Access to Telisotuzumab Adizutecan

Sponsor: AbbVie. Phase: . Conditions: Solid Tumors

full page →ctgov ↗
← prev
page 99 of 114
next →